Back to news list

Related News

RECIST disease assessment is effective for targeted treatment as well as classical chemotherapy

5 Apr 2019

EGAM 2019 awardees for best recruiting group, trial and institute

14 Mar 2019

Use of prognostic tool reveals benefit in negative sarcoma trial

26 Feb 2019

RECIST disease assessment is effective for targeted treatment as well as classical chemotherapy

5 Apr 2019

EGAM 2019 awardees for best recruiting group, trial and institute

14 Mar 2019

Retrospective Analysis of Two EORTC Studies Showed That Gastric Acid Suppressants May Negatively Impact Survival Outcomes in Sarcoma Patients Treated With Pazopanib

25 Feb 2019

RECIST disease assessment is effective for targeted treatment as well as classical chemotherapy

5 Apr 2019

EGAM 2019 awardees for best recruiting group, trial and institute

14 Mar 2019

Use of prognostic tool reveals benefit in negative sarcoma trial

26 Feb 2019